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Molecular chaperones are key components in the maintenance of cellular homeostasis and survival, not only during stress but
also under optimal growth conditions. Folding of nascent polypeptides is supported by molecular chaperones, which avoid the
formation of aggregates by preventing nonspecific interactions and aid, when necessary, the translocation of proteins to their correct
intracellular localization. Furthermore, when proteins are damaged, molecular chaperones may also facilitate their refolding or, in
the case of irreparable proteins, their removal by the protein degradation machinery of the cell. During their digenetic lifestyle,
Leishmania parasites encounter and adapt to harsh environmental conditions, such as nutrient deficiency, hypoxia, oxidative stress,
changing pH, and shifts in temperature; all these factors are potential triggers of cellular stress. We summarize here our current
knowledge on the main types of molecular chaperones in Leishmania and their functions. Among them, heat shock proteins
play important roles in adaptation and survival of this parasite against temperature changes associated with its passage from the
poikilothermic insect vector to the warm-blooded vertebrate host. The study of structural features and the function of chaperones
in Leishmania biology is providing opportunities (and challenges) for drug discovery and improving of current treatments against
leishmaniasis.
1. The Stressful Life of Leishmania Parasites
There is growing body of evidence that chaperones play
important roles in the life cycle of a wide variety of important
human pathogens [1, 2]. In particular, the life cycle of
insect-transmitted parasites entails multiple changes in envi-
ronmental conditions, including temperature, pH, oxidative
stress, and nutrient deprivation. These stressful conditions
may damage important cellular structures and interfere with
essential functions of the parasites.
Parasites of the genus Leishmania cause leishmaniasis in
humans and in a variety of vertebrate hosts. In humans, leish-
maniasis constitutes a group of diverse diseases ranging in
severity from a spontaneously healing skin ulcer to over-
whelming visceral disease [3]. Above 350 million people are
currently at risk of acquiring the various forms of the disease,
and it was estimated that approximately 0.2 to 0.4 million
of visceral leishmaniasis (VL) cases and 0.7 to 1.2 million
cutaneous leishmaniasis (CL) cases occur each year [4]. CL
has a spectrum of presentations, typically with self-healing or
chronic lesions on the skin. In some cases, after resolution of
the initial cutaneous lesion, metastasis of the parasite occurs
and tissue destruction appear on the buccal or nasal mucosa,
process known as mucocutaneous leishmaniasis (MCL).
Around 20 Leishmania species are pathogenic for
humans, and they are spread by the bite of an infected sandfly
(phlebotomines of the genera Phlebotomus, Lutzomyia, and
Psychodopygus), which transmits the promastigote stage of
the parasite into the human skin. Promastigotes are phago-
cytosed by macrophages, either directly or after initial uptake
by neutrophils, and are delivered to the mature phagolyso-
some compartment where they differentiate to the nonmotile
amastigote stage. Thus, Leishmania spp. undergo a complex
life cycle involving progression from the insect vector (pro-
mastigote stage, with an anterior flagellum) to a mammalian
host (amastigote stage with only a very short flagellum) and
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back again [5]. During its life cycle, the parasite continually
cycles between a poikilothermic insect vector and a warm-
blooded vertebrate host and therefore experiences repeated
episodes of heat shock and oxidative stress, among other
environmental changes [6].
The aim of this review is to survey the molecular chap-
erone compendium in this parasitic protist and what is
known about how these molecules contribute to alleviate the
molecular consequences of the stressful environmental con-
ditions that the parasite must cope in its intracellular and
extracellular lifestyles. Beyond their roles for cytoprotection
against stress, parasite heat shock proteins (HSPs) have been
implicated in differentiation, stage development, and viru-
lence. Although many chaperones have been shown to elicit
strong immunological responses in infected individuals, their
usefulness as potential vaccine candidates has been reviewed
elsewhere [7] and this issue will not be discussed in this
review.
2. Molecular Chaperones
In the cell, at any given time, hundreds of macromolecular
processes involving proteins are occurring. In the cytosol,
proteins are present at extremely high concentration (over
300mg/mL); therefore, protein-protein interactions must
be governed and modulated appropriately [9]. The modern
concept of protein quality control refers to those cellular
processes that regulate protein synthesis, folding, unfolding,
and turnover, and it is mediated by chaperone and protease
systems. The quality control systems have essential roles in
the life of cells, ensuring that proteins are correctly folded and
functional at the right place and time. Molecular chaperone
is the term used for referring to any protein that shares the
ability to interact with nonnative conformations of other
proteins. Molecular chaperones aid in the folding of nascent
polypeptides as they are synthesized by ribosomes, transit
across cellular and organelle membranes, disassembly of
macromolecular complexes or aggregates, and quality control
processes, as well as the regulation of conformational changes
that affect biological functions of proteins [10, 11]. More
recently, the term chaperome has been coined for the inter-
connected network ofmolecular chaperones as well as cocha-
perones that assist in their function [12, 13]. The chaperones
have the ability to distinguish between unfolded, misfolded,
and native protein conformers. Of particular importance is
the shielding of hydrophobic residues, which are temporally
exposed during initial folding but also upon damaging of
existing proteins. Uncontrolled exposure of hydrophobic
stretches leads to protein aggregation and has fatal conse-
quences. Hence, chaperones bind to exposed hydrophobic
segments of substrate proteins (often named “client” proteins)
with the objective of preventing the formation of stable, irre-
versible protein aggregates, thereby facilitating their appro-
priate folding. In addition to preventing aggregation, some
chaperones are endowed with ATPase activity and use the
energy of ATP hydrolysis to actively unfold protein substrates
in order to accelerate the conversion of stable misfolded
structures into stable native conformations.
Table 1: Main classes of molecular chaperones.
Family name Functions
HSP100 Unfolding, solubilisation of aggregates, proteolysis
HSP90
Protein maturation of steroid receptors, protein
kinases, and other components of cellular
signalling pathways. Organelle-specific variants
exist
HSP70
Nascent-protein folding, refolding of denatured
proteins, and translocation across membranes.
Organelle-specific variants exist
HSP60/
chaperonins
Protein folding and prevention of aggregation
(bacterial and mitochondrial proteins)
CCT (TRiC) Folding of cytoskeleton components
HSP40 Hsp70 ATPase activators and intrinsic chaperoneactivity
Small HSPs
(sHSPs)
Prevention of aggregation, probable role in
membrane homeostasis
Both extra- and intracellular stresses have a deleterious
impact on protein structure and function. In order to coun-
teract these effects, cells have developed the stress response, in
which molecular chaperones are the central components. In
fact, becausemanymolecular chaperones were first identified
as being induced by heat shock or other stresses, they are
known as heat shock proteins or stress proteins [14].The pre-
dominant classes were grouped according to their apparent
molecular weights: small HSPs (sHSPs), HSP60, HSP70,
HSP90, andHSP100. Table 1 summarizes themain families of
molecular chaperones. These families of chaperones are ubi-
quitous and conserved in most organisms, from bacteria to
higher eukaryotes.
However, our understanding of the roles played bymolec-
ular chaperones in human parasites is lagging behind,
although important progress has been made recently and
warrants this review. Our main goal was to present the com-
position of the different chaperone families in Leishmania, by
mining genome databases (the L. major genome annotation
has been chosen as reference), and describing their known
functions, by reviewing the scientific literature. Thus, our
final aim is to provide a framework that may facilitate and
stimulate the study of the implications of these proteins in
the biology of this human pathogen that causes fearsome
diseases.
3. HSP100/Clp Family
Protein aggregates are detrimental to the cell; therefore, living
systems possess a plethora ofmolecular chaperones dedicated
to avoid protein aggregation. In case this fails, there are two
ways to solve the problem: destruction of the aggregates by
the action of elaborate protease systems or nondestructive
disaggregation. Chaperones of the HSP100 family has the
unique capability of recognizing misfolded proteins within
an aggregate and actively unfolding them, ultimately disas-
sembling the insoluble structure and delivering substrates
into refolding pathways. Giving this peculiar ability, that is,
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to pull protein from aggregates, they have been named as
“disaggregates” [17]. For this formidable task, that is, the
nondestructive disaggregation of protein aggregates, HSP100
chaperones work in combination with the HSP70/DnaK cha-
perone machinery. Also, in the task of avoiding irreversible
protein aggregation, the role played by sHSPs seems to be very
relevant [18].
The HSP100/Clp family of chaperones belongs to the
superfamily of AAA+ domain-containing ATPases. The
defining feature of the superfamily is the AAA+ domain,
which consists of an 𝛼–𝛽 subdomain and a smaller, helical
subdomain [19]. Most AAA+ proteins form oligomeric ring
structures with ATP binding site close to the interface bet-
ween subunits, and the neighboring subunit contributes the
so-called arginine finger for ATP hydrolysis [20]. HSP100
proteins are subdivided into two classes based on the number
of AAA+ domains. Class 1 HSP100s form hexameric struc-
tures and contain two different nucleotide-binding sites in
eachmonomer [21]. Bacterial proteins ClpA, ClpB, ClpC, and
ClpE as well as yeast HSP104 belong to this class. Class 2
HSP100s contain only one nucleotide bindingmodule; exam-
ples are the bacterial ClpX and ClpY, and the AAA+ ATPase
p97/Cdc48 inmammals [22]. HSP100 proteins are thought to
pull misfolded proteins through the central pore of the hex-
americ ring, enabling the proteins to become refolded [23].
On the other hand, HSP104 is one of themajor heat shock
proteins that contribute to acquire thermotolerance [10].
Notably HSP104 is also involved in yeast prion inheritance
[24].
An orthologue to the yeast HSP104 gene was cloned in L.
major (systematic name LmjF29.1270); the encoded protein
was named HSP100 because of its apparent molecular weight
and the fact that its expression increased dramatically after
incubation of Leishmania promastigotes at elevated tempera-
tures [25].TheHSP100 has been found to be expressed prefer-
entially in amastigotes, whereas it was found to be dispensable
in the promastigote stage [26]. However, although an initial
delay in lesion development was observed in BALB/c mice
experimentally infected with an L. major Δhsp100 mutant,
finally the lesions reached a similar size to those caused by
the L. major wild-type line.This argues against a requirement
of HSP100 for the intracellular proliferation of fully differ-
entiated amastigotes and suggests that the loss of HSP100
chiefly affects processes in the initial phase of an infection,
that is, development from the promastigote to the amastigote
stage [26]. In fact, after repeated mouse infection cycles, an
escape variant with restored infectivity and pathogenicity was
obtained [27].
In L. donovani, the expression of HSP100 is required for
normal development of the parasite inside mammalian host
cells but it is dispensable for axenic growth. Also, it has been
postulated that HSP100 may act as an antagonist for the ama-
stigote-to-promastigote differentiation process [28].
LeishmaniaHSP100 has been found to play a very relevant
function in exosome biogenesis. Thus, proteomic analysis
showed that exosomes from the wild-type and a Δhsp100
L. donovani mutant have distinct protein cargo, suggesting
that packaging of proteins into exosomes is dependent in
part on HSP100. Furthermore, it was found that exosomes
fromwild-typeL. donovani failed to primemonocyte-derived
dendritic cells to drive the differentiation of naive CD4+
T cells into IFN-𝛾–producing Th1 cells, whereas exosomes
derived from the Δhsp100 mutant line promoted the dif-
ferentiation of naive CD4+ lymphocytes into Th1 cells [29].
These findings demonstrate that Leishmania exosomes are
predominantly immunosuppressive, and it can be postulated
that HSP100 is modulating the composition of the exosomal
cargo.
In the L. major genome, there are two identical genes
(LmjF02.0710 and LmjF27.2630), encoding for a protein
(annotated as HSP78) that is more similar to the E. coli ClpB
protein than to the LeishmaniaHSP100 [15]. It is possible that
HSP78 locates at the mitochondria (or kinetoplast) of Leish-
mania, but this has not been experimentally addressed. Also,
in the L. major database, there is another gene (LmjF.30.1700)
coding for a predicted protein with a region, comprising
amino acids 324–473, that conforms the typical ATPase
domain of the AAA+ superfamily.
Putative class 2 HSP100s in Leishmania are encoded by
genes LmjF.15.0090 and LmjF.09.0230, which show remark-
able sequence conservation with E. coli ClpY. In E. coli, ClpY
(HslU) and ClpQ (HslV) are heat shock proteins involved in
the proteolysis of misfolded proteins; both proteins form a
complex known as either HslVU or ClpYQ [30]. The protein
encoded by gene LmjF.15.0090 is annotated as HslU1 and that
encoded by gene LmjF.09.0230 as HslU2, due to the fact that
the orthologous proteins have been studied in the related try-
panosomatid Trypanosoma brucei [31]. The L. major HslV is
encoded by gene LmjF36.3990. By epitope tagging, TbHslVU
proteins have been localized into the T. bruceimitochondria,
where they are associated with the mitochondrial genome,
kinetoplast DNA (kDNA). Of particular note is the finding
that silencing by RNAi of the corresponding genes dra-
matically affects the kDNA replication and segregation [31].
Recently, the relevance of HslU proteins has been addressed
in L. donovani [32]. It was found that the loss of HslU2 does
not impair viability, even though a reduced growth of the
promastigote stage was observed. However, the attempts to
create HslU1 null-mutants failed, and the loss of a single
allele resulted in reduced growth and unusual morphology,
suggesting a vital role for this protein. Furthermore, results
shown in this study argued against an association between
HslV and the HslU proteins in L. donovani [32]. However,
these findings have been questioned in a recent report,
in which the mitochondrial localization of proteins HslU1,
HslU2, and HslV in L. major procyclic promastigotes has
been definitively established [33].
4. HSP90 Family
HSP90s are among the most abundant proteins, even in
unstressed cells.Members of this family are found in the cyto-
plasm, endoplasmic reticulum (ER), and mitochondria, and
they are named differently regarding their subcellular loca-
tion: HSP90 (often referred as HSP83) for the cytoplasmic
form, Grp94 (gp96 or endoplasmin) for the ER form, and
TRAP1 (or HSP75), which is located in the mitochondrial
matrix. Although HSP90 can bind to misfolded proteins and
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Figure 1: Overview of the HSP90 chaperone cycle. In the initial step, protein substrate bound to the HSP70-HSP40 chaperones interacts with
HSP90; the formation of this complex is induced by HOP. ATP binding to HSP90 induces a conformation change in the complex, which leads
to the substrate transfer from HSP70 to HSP90, and the release of the HSP70-HSP40 chaperones; the substrate-HSP90 complex is stabilized
by p23 binding. Finally, the hydrolysis of ATP induces additional conformation changes leading to substrate release.
prevent their aggregation, it is accepted that HSP90s do not
act in protein folding as general chaperones. More often, they
are required for the activation and/or stabilization in a native
state of a defined set of proteins, known as “clients.” Many
of these clients are transcription factors and protein kinases
involved in the control of cell homeostasis, proliferation, dif-
ferentiation, and apoptosis [34, 35]. Since HSP90 clients are
hubs of diverse signaling networks and participate in nearly
every cellular function, HSP90s represent connectors for
many regulatory circuits and link them to environmental
impacts [36].
On the other hand,HSP90 acts as a buffer for genetic vari-
ation by rescuing mutated proteins with altered properties.
Such a reservoir function has been suggested to be extremely
relevant in driving evolutionary changes [37]. Support for
this hypothesis has been obtained in studies investigating
the developmental effects of HSP90 inhibitors on Drosophila
melanogaster and Arabidopsis thaliana, and from studies
examining the effects of environmental stresses in yeast [38].
The functionalHSP90 chaperone is a flexible dimeric pro-
tein composed of three functional domains: the N-terminal
nucleotide-binding domain (NBD); the middle domain
(MD), which is also involved in ATP hydrolysis and it is
the site for client and cochaperone binding; and a C-terminal
dimerization domain (DD). A conserved MEEVD motif at
the C-terminal end serves as the docking site for the inter-
action with cochaperones which contain the tetratricopep-
tide repeat- (TPR-) domain. Some cochaperones and client
proteins interact with HSP90 through its NBD domain [39].
The NBD is also the binding site for the HSP90-specific
inhibitors geldanamycin and radicicol [40]. The domain
interfaces between NBD and MD and between MD and DD
are dynamic, resulting in an ensemble of conformations.
In eukaryotic cells, the ATPase cycle of HSP90 is intima-
tely coupled to the HSP70 chaperone machinery (Figure 1).
In fact, the emergingmodel is that client proteins do not bind
directly to HSP90 but instead the client-substrates are firstly
bound by HSP70, which control substrate influx to HSP90
[41]. Moreover, to achieve its function, HSP90 requires the
participation of different cofactors (termed cochaperones)
to facilitate the maturation of client proteins. To date, more
than 20 cochaperones have been identified; they regulate the
activity ofHSP90 anddetermine the interactionswith specific
client proteins [10, 42].Thus, the composition of cochaperone
complexes seems to depend on the particular client protein
that is beingmodulated by theHSP90 heterocomplex. HSP90
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is also regulated posttranslationally through chemical mod-
ifications, including phosphorylation, acetylation, methyla-
tion, and S-nitrosylation, and even ubiquitination has been
reported [36, 43, 44].
First work describing the presence of the HSP90 gene in
Leishmania and T. brucei was done by Van der Ploeg and
coworkers [45]. Afterwards, research from many other
groups allowed the characterization of the three typicalmem-
bers (cytosolic,mitochondrial, andER resident) of theHSP90
family (reviewed in [15]). The cytoplasmic member, more
often dubbed HSP83 in Leishmania, is encoded by a large
number of genes tandemly organized. Thus, for example,
in the L. major genome there are 17 HSP90 (HSP83)
genes tandemly organized (from gene LmjF33.0312 to gene
LmjF33.0365).This high gene copy number is probablymain-
tained because the high level of HSP90 protein that the par-
asites need to express. It was determined that, in unstressed
Leishmania promastigotes, HSP90 make up 2.8% of the total
protein [46]. In contrast, the ER paralogue of theHSP90 fam-
ily, named Grp94, was found to be encoded by a single-copy
gene [47]. Remarkably, this protein in L. donovani has been
found to be involved in lipophosphoglycan (LPG) synthesis
[48]; LPG is the predominant surface glycoconjugate in both
procyclic and metacyclic stages. Finally, the mitochondrial
member (named TRAP-1 or HSP75) of the HSP90 family is
encoded in the L. major genome by gene LmjF33.2390, even
though no further characterization of this protein has been
described until now.
4.1. HSP90 as a Triggering Factor of Stage Differentiation in
Leishmania. The ability of HSP90 machinery to sense and
respond to environmental stimuli has been exploited by pro-
tozoan parasites such as Plasmodium, Eimeria,Theileria, Tox-
oplasma [49], and Trypanosoma, among others (reviewed in
[50]). In Leishmania, the first evidence about the pivotal role
played by HSP90 in stage differentiation from promastigote
to amastigote was found in L. donovani by treatment of
parasites with HSP90-specific drugs such as geldanamycin or
radicicol. These chemotherapeutic agents bind to the ATP-
binding pocket of HSP90, inhibiting specifically the function
of the protein [40]. Treatment of Leishmania promastigotes
with geldanamycin induces a morphological differentiation
towards amastigote-like forms, and the expression of amasti-
gote-specific proteins is concomitantly observed [51]. It
should be noted that the morphological changes experienced
by the parasites upon geldanamycin treatment were very
similar to those induced by heat shock, which itself has also
been shown to induce differentiation. A detailed biochemical
characterization of the interaction between geldanamycin
and the L. braziliensisHSP90 has shown that this compound
inhibits the LbHSP90 ATPase activity with an IC
50
of 0.7𝜇M
[52]. Thus, all these data suggest that a decrease in the levels
of available HSP90 by either enrolment in the heat shock
response or artificial inactivation by drugs may be the trigger
for stage differentiation. In this regard, variations in the levels
of de novo HSP90 synthesis were reported to exist naturally
along the promastigote-to-amastigote differentiation process
in axenic conditions [53]. Altogether, these findings point
to the HSP90 cellular homeostasis as a key factor for the
control of stage differentiation in Leishmania [6]. This idea
is based also on the proved involvement of HSP90 in the
regulation of cellular growth and differentiation in different
organisms [38]. More recently, it has been suggested that
HSP90 would be acting as a possible antagonist to HSP100,
which has been linked to the amastigote-differentiation pro-
cess [54].
4.2. HSP90 Cochaperones in Leishmania. As stated above,
HSP90 is assisted by a plethora of cochaperones, which are
involved in different stages of the HSP90 functional cycle,
often contribute to the selection of client proteins chaperoned
byHSP90, and facilitate client maturation by interacting with
distinct regions on HSP90. So far, only limited information
exists with regard to the complexes formed by HSP90 and its
cochaperones in Leishmania. A comprehensive list of putative
components of HSP90-heterocomplexes in several protozoan
parasites, including Leishmania has been published recently
[55]. The first experimentally confirmed cochaperone for
HSP90 in Leishmania was STI1/HOP [56]. The synthesis of
this protein is upregulated by heat shock, and coimmunopre-
cipitation experiments indicated that the Leishmania protein
forms a salt-sensitive complex with HSP90 and HSP70. In L.
major, the protein STI1 is encoded by gene LmjF08.1110. In
recent works, indirect evidence on an essential role for STI1 in
L. donovani promastigotes has been reported [57, 58]. STI1 is
widely conserved and it has been found in diverse organisms;
however, it is named differently depending on the organism.
Thus, in yeast, the protein is also named STI1 whereas
the mammalian orthologue is called HOP (HSP90/HSP70-
organizing protein). The protein plays at least two relevant
roles in the HSP90 functional cycle. First, it is an ATPase
regulator (inhibitor) that binds to the EEVD sequence in
the C-terminus and to other domains of HSP90 in the open
conformation [59].The second critical activity is the ability to
simultaneously bind bothHSP90 andHSP70 through distinct
tetratricopeptide repeat (TPR) sites existing in the molecule
[10]. Another gene, LmjF36.0070, is annotated in the L. major
genome database as “stress-inducible protein STI1 homolog.”
However, apart from the presence of TPR motifs, both
proteins share low sequence conservation [15]. In a recent
work, both alleles for the LmjF36.0070 orthologue, which
was named “hop2,” were successfully deleted in L. donovani
promastigotes; the resulting null line did not show growth
defects or loss of infectivity for macrophages, suggesting a
nonessential role for this protein at least for in vitro growth
[60]. In the same work, gene encoding a protein similar
to HIP (HSC70 interacting protein), another HSP90/HSP70
cochaperone, was found to be also dispensable for growth of
L. donovani promastigotes and for in vitro multiplication in
macrophages [60].
The orthologue to protein SGT (small glutamine-rich
tetratricopeptide repeat), another cochaperone for HSP90/
HSP70, has been also characterized in L. donovani. In this
case, repeated failures in obtaining a nullmutant line by gene-
replacement point to an essential role of this protein for pro-
liferation of the parasite [61]. SGT is encoded in the L. major
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genome by gene LmjF.30.2740. Coimmunoprecipitation anal-
ysis showed a direct interaction of SGT with HSP70, HSP90,
and Sti-1/HOP [61].
The cochaperone Aha1 also plays a very relevant role in
the ATP-drivenHSP90 cycle [62].The intrinsic ATPase activ-
ity of HSP90 is relatively weak, and Aha1 stimulates it several
folds. The biochemical and biophysical characterization of
L. braziliensis Aha1 (LbAha1) has been published recently
[63]. LbAha1 was found to stimulate the ATPase activity of
LbHSP90 by around 10-fold; in addition, a model in which
two LbAha1molecules interacts with the LbHSP90 dimerwas
postulated [63]. The gene encoding for Aha1 in the L. major
genome database is annotated as LmjF.18.0210.
The cochaperone p23 associates with HSP90 late in the
chaperone cycle (Figure 1), facilitating the maturation of
client proteins [38]. In the L. major genome databases, two
evolutionarily divergent p23-homologues, encoded by genes
LmjF34.0210 and LmjF35.4470, were identified by sequence
homology analysis [15]. In a recent work, both p23 proteins
from L. braziliensis (named Lbp23A and Lbp23B) were pro-
duced as recombinant proteins in order to perform structural
and functional studies [64]. Lbp23A and Lbp23B are the
orthologs to the proteins encoded by genes LmjF35.4470
and LmjF34.0210, respectively. Both proteins were found to
interact with L. braziliensis HSP90, inhibiting its ATPase
activity [64]. Moreover, it was found that both proteins have
intrinsic chaperone activity, based on its ability to prevent the
thermal aggregation of two model proteins: malic dehydro-
genase (MDH) and luciferase. Given the structural similarity
existing between p23 and the 𝛼-crystallin domain of small
heat shock proteins (sHSPs), it is possible that some of these
Leishmania proteins might be actually a sHSP (see below).
Some cyclophilins (or immunophilins) have been found
to be associated with HSP90 complexes and, therefore, cate-
gorized as cochaperones [65]. Cyclophilins are protein chap-
erones with PPIase activity, which catalyses the cis-trans-
isomerization of peptidylprolyl bonds, affecting stability, act-
ivity, and localization of client proteins [66]. An in silico
study has shown that the superfamily of immunophilins in L.
major comprises 17 members [67]. Recently, the L. donovani
chaperone cyclophilin 40 (L. major ortholog: LmjF.35.4770)
has been shown to be essential for intracellularmultiplication
in macrophages [68].
To date, around 300 bona fide HSP90 clients have been
identified in different organisms. Among these, two domi-
nant groups have been distinguished, specifically, transcrip-
tion factors and kinases, most of which participate in signal
transduction pathways of cell growth and differentiation.
Other clients include DNA- and RNA-binding proteins (inc-
luding polymerases), ribosomal proteins, small GTPases,
cytoskeletal proteins, and ion channels. Also, many viruses
hijack Hsp90s for maturation of their proteins [36]. However,
in Leishmania, the number of putative client proteins of
HSP90 that have been demonstrated experimentally to date
is low. Adriano and coworkers [69] demonstrated the inter-
action betweenHSP90 and the cytoplasmic Leishmania silent
information regulator 2 SIR2RP1.The SIR2RP1 ortholog in T.
brucei has been described as a chromosome-associatedNAD-
dependent enzyme involved in DNA repair and catalyzes
both deacetylation and ADP ribosylation of histones [70].
On the other hand, reverse genetic techniques have shown
that SIR2RP1 is critical for survival and/or proliferation of L.
infantum [71].
5. The HSP70 Family
Soon after discovering of heat shock proteins (HSPs) it
became clear that the accumulation of a 70 kDa protein,
which was designated heat shock protein 70 (HSP70), was
intimately linked to the heat shock response and its accu-
mulation was associated with an enhanced cell survival to
stressful conditions [72]. Subsequent research revealed that
HSP70 is essential for protection against stresses that cause
protein denaturation, and that, in nonstressed cells, there
exist constitutively expressed HSP70 proteins, which are per-
forming house-keeping roles related with protein folding.
Based on this finding these proteins were named also chaper-
ones; the house-keeping functions of HSP70 chaperones inc-
lude transport of proteins between cellular compartments,
removal of misfolded proteins, folding and refolding of pro-
teins, prevention and dissolution of protein aggregation, and
control of regulatory proteins. HSP70s also cooperate with
other ATP-dependent chaperones including HSP90 and cha-
peronins to fold some substrates, and with certain proteins
of the AAA+ family to dissociate aggregates of misfolded
proteins (reviewed in [73–75]).
As a reflection of its essential and crucial functions,
HSP70 is, by far, the most conserved protein present in all
organisms [76]. Moreover, most eukaryotic organisms have
several HSP70 variants localized in all major subcompart-
ments, the cytosol, the nucleus, ER, mitochondria, and also
chloroplasts [74, 77]. For example, the yeast Saccharomyces
cerevisiae contains nine Hsp70 homologs [77]. Similarly, the
humanHSP70 family comprises tenmembers that differ from
each other by amino acid sequence, expression level and sub-
cellular localization [77]. Even inEscherichia coli (K-12), three
distinct HSP70 (DnaK) genes exist [78]. Among parasites,
six structural different HSP70s are present in Plasmodium
falciparum [79] and nine different members of the HSP70
family are encoded in the genome of Leishmania (Table 2)
and related trypanosomatids [15]. HSP70 family members
located in the endoplasmic reticulum are known as BiP or
Grp78, and those found in the mitochondria are named
mtHsp70, Grp75, or mortalin (a term only used when refer-
ring to mitochondrial HSP70 members in mammals).
The eukaryotic HSP70s constitute a super-family consist-
ing of two major families, recently classified as the typical
HSP70 family (described above) and the atypical HSP110/
GRP170 family [80].The domain architectures of HSP110 and
Grp170 are very similar to that of HSP70s; the main differ-
ences lie in large acidic insertions between the peptide bind-
ing domain (PBD) and the lid, and also at the C-termi-
nus. Whereas the function of the Grp170 group is limited to
ER, HSP110s are found in the cytoplasm. Although their bio-
chemical roles remained elusive, it is belief that they are not
active as protein folding chaperones. MammalianHsp110 and
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Table 2:Members of theHSP70 family inL.major and their putative
orthologs in humans.
L.major protein1
(GeneDB identifiers)
Human protein2
(UniProt ID)
HSP70 (LmjF.28.2770,
LmjF28.2780)
Hsp70-1a/HSPA1A (P08107);
Hsp70-1t/HSPA1L (P34931);
HSPA6 (P17066)
Hsp70-2/HSPA2 (P54652)
Hsc70/HSPA8 (P11142)
BiP or Grp78 (LmjF.28.1200) BiP/HSPA5 (P11021)
HSP70.c (LmjF28.2820)
Hsp70-14 (Q0VDF9)
MtHSP70-1
(LmjF30.2460–2490,
LmjF30.2550)
MtHSP70/HSPA9 (P38646)
HSP70.4 (LmjF.26.1240)
HSP70.a (LmjF.01.0640)
HSP70.b (LmjF.26.0900)
HSP110 (LmjF.18.1370) Hsp110/HSPA4 (P34932)
HSP110 (LmjF.18.1370) Hsp110-2/HSPA4L (O95757)
HSP110 (LmjF.18.1370) Hsp105/HSPH1 (Q92598)
GRP170 (LmjF.35.4710) Grp170/HSPH4 (B7Z2N4)
1Nomenclature according to Folgueira and Requena [15]. GeneDB accession
numbers are shown in brackets.
2Nomenclature according to Kampinga and Craig [16]. UniProtKB accession
numbers are shown in brackets.
yeast Sse1p were shown to functionally and physically inter-
act with prototypical HSP70s, acting as potent nucleotide
exchange factors (NEFs) for the HSP70 counterpart [81].
5.1. The HSP70 Chaperone Machine. All cellular functions of
HSP70 chaperones seem to depend on an ATP-driven mech-
anism by which polypeptides are bound to and released from
HSP70 [82]. It has been suggested that the ATP-driven cycle
of HSP70 operates by a bidirectional heterotrophic allosteric
mechanism [83]. The structure of the different members of
the Hsp70 family is highly conserved, consisting of an N-
terminal ATPase domain (also named adenine nucleotide-
binding domain or NBD) of c. 45 kDa and a C-terminal sub-
strate binding domain of c. 25 kDa, which is further sub-
divided into a beta-sandwich subdomain with a peptide-
binding cleft and a C-terminal alpha-helical subdomain that
acts as a lid, covering the peptide binding site [73]. The inter-
domain linker, connecting the NBD to the peptide binding
domain (PBD), is highly conserved and plays a critical role in
the allosteric regulation during the HSP70 functional cycle
[84]. Also, many HSP70s also contain a G/P-rich C-terminal
region that ends in the EEVD-motif, which mediates their
binding to the TPR-domain containing cochaperones. The
TPR is characterized by a 34-amino acid motif that forms an
antiparallel 𝛼-helical hairpin [85]. Two important cochaper-
ones, HOP and CHIP, bind EEVD-motif (also present in the
C-terminal end of HSP90) by their TPR domains. In fact, the
TPR-protein HOP forms a link between HSP90 and HSP70
(Figure 1), facilitating protein client transfer between both
chaperones [86].
Figure 2 shows the so-called ATPase cycle of HSP70, con-
sisting of an alternation between the ATP-bound state, with
low affinity and fast exchange rates for polypeptide substrates,
and theADP-bound state, with high affinity and low exchange
rates for substrates [87]. Although ATP hydrolysis is basic for
chaperone activity of HSP70s, the intrinsic ATP hydrolysis
rates of HSP70s are generally low. Nevertheless, this low
intrinsic ATPase activity is stimulated by the recruitment and
binding of J-type chaperones of theHSP40 family (see below)
and the polypeptidic substrate [88]. Thus, the encounter
between the substrate and the HSP70-ATP complex results in
ATP hydrolysis, and, as a result, the substrate is trapped in the
HSP70-ADP complex, which has a low peptide dissociation
rate.Themodulation of the affinity for polypeptidic substrates
would be triggered by a conformational change in the lid
domain that, upon ATP hydrolysis, closes on the substrate
that is located within the PBD.This high affinity of the ADP-
bound state of HSP70s to unfolded polypeptides allows these
chaperones to prevent efficiently the aggregation ofmisfolded
proteins. Also, it has been proposed that HSP70 uses the
energy of ATP hydrolysis to recruit a force of entropic origin
to locally unfold aggregates or pull proteins across mem-
branes [87, 89].
HSP70s are assisted by a group of cochaperones, being the
most important the family of HSP40 (also known as DnaJ-
like proteins or J domain proteins, JDPs) and several mole-
cules acting as nucleotide exchange factors (NEFs). JDPs, in
the present of the polypeptidic substrate, stimulate greatly the
ATPase activity of HSP70s [90]. HSP40 is thought to act as
the primary substrate recruiter for HSP70 and to stimulate
the HSP70 ATPase activity. In most organisms, the HSP40
family is composed bymanymembers, and Leishmania is not
an exception (see below).
In order to release the polypeptide from the hsp70-
substrate, taking into account the high affinity of HSP70 to
the substrate in the ADP-bound state and the physiological
ATP concentrations, the engagement of NEFs to the HSP70-
substrate complexes is crucial.Thus, NEFs trigger the dissoci-
ation of boundADP fromHSP70 to allow the binding of ATP,
resetting the cycle (Figure 2). To date, four different families
of NEFs for Hsp70s have been described: the GrpE family
in prokaryotes and organelles of prokaryotic origin, the Bag
family in the eukaryotic cytosol, the HspBP family in the
eukaryotic cytosol and endoplasmic reticulum, and HSP70-
related proteins in the eukaryotic cytosol (HSP110) and endo-
plasmic reticulum (Hsp170 or Grp170) [20, 91]. These four
groups of proteins have entirely different structures; there-
fore, their nucleotide exchange role seems to be arisen by con-
vergent functional evolution.
Some other proteins have also been identified as HSP70
cofactors, such as HIP, HOP, and CHIP [92]. HIP interacts
with theATP-binding domain of theHSP70, and it cooperates
with J domain proteins in increasing ATP hydrolysis and
further stabilizes the HSP70-substrate interaction [93]. HOP
binds to the carboxyl-terminal domain of HSP70, and also to
HSP90, mediating the association of these molecular chap-
erones [86]. Human CHIP is a cytosolic protein containing
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Figure 2: Overview of the HSP70 chaperone cycle. In the initial step, the substrate (unfolded protein), bound to the HSP40, forms a complex
with the HSP70 in its ATP-loaded state. ATP hydrolysis promotes the transfer of the substrate to the peptide-binding pocket of HSP70.
Following substrate transfer,HSP40 leaves the complex and the nucleotide exchange factor (NEF) is recruited to theHSP70-substrate complex,
stimulating the ADP-ATP exchange in HSP70. ATP binding to HSP70 induces a conformational change leading to the release of both NEF
and substrate.
three TPR domains at its amino-terminal moiety, by which
this cochaperone interacts with the carboxyl-termini of both
HSP70 and HSP90. In addition, CHIP possesses a U-box
domain endowed with E3 ubiquitin ligase activity. Hence,
CHIP provides a link between the processes of protein folding
and protein degradation [94].
Some structural features of HIP from L. braziliensis have
been studied in a recent work, and the results indicated that
the protein forms a dimerwith an elongated structure, similar
to the HIP protein in mammalians [95].
5.2. Chaperones of the HSP70 Family in Leishmania. In
Table 2 are listed the members of the HSP70 encoded in
the L. major genome and their putative orthologues existing
in humans. The phylogenetic tree shown in Figure 3 was
constructed with the aim of illustrating possible relationships
existing between the differentmembers of LeishmaniaHSP70
family and the closest orthologs in humans. Thus, this
analysis confirmed the existence in Leishmania of all HSP70
groups composing the eukaryotic HSP70 family: cytosolic
HSP70s, ERHSP70 (BiP), mitochondrial HSP70, andHSP110
subfamily. This study shows that Leishmania contains two
distinct members of the Grp170 group, that is, GRP170 and
HSP70.a, whereas a sole member exists in humans. Addi-
tionally, Leishmania parasites possess three HSP70 variants
(HSP70.4, HSP70.b, andHSP70.c) that have no clear relatives
in humans. Conversely, orthologue to the human Hsp70-14
does not seem to exist in Leishmania. Among the atypical
HSP70s in Leishmania, the localization of HSP70.4 in L.
major was investigated by indirect immunofluorescence and
the results indicated that the protein is cytoplasmic, even in
periods of stress [96]. Interestingly, the phylogenetic analysis
(Figure 3) shows that HSP70.4 groups with prototypical cyto-
plasmic HSP70s. Sequence analysis of Leishmania HSP70.b
indicates that the protein is more similar to cyanobacterial
DnaK than to the mitochondrial HSP70s [15]. As cyanobac-
teria are considered the origin of chloroplasts [97], this find-
ingmay represent a further support to the idea that the ances-
tor of Leishmania, and the rest of trypanosomatids, pos-
sessed chloroplasts [98, 99]. Nevertheless, current location
of HSP70.b in Leishmania remains to be determined. An
indirect indication of the relevance of the different members
of HSP70 superfamily is found in the fact that an equivalent
complement of HSP70s exists in two other trypanosomatids:
T. brucei andT. cruzi [15, 100], which contains orthologues for
all the subdivisions of the Leishmania Hsp70 protein family.
Recently, the HSP70.c ortholog in T. brucei has been bio-
chemically characterized regarding its chaperone function
[101]. It was shown that this protein, located in the cytoplasm,
interacts with Tbj2 (a member of HSP40 family; ortholog to
protein J2; see Table 3). Both proteins, expressed and purified
as recombinant proteins, are active in preventing thermal
aggregation of MDH and rhodanese. Moreover, it was found
that Tbj2 stimulates the ATPase activity of TbHsp70.c [101].
Genes encoding for prototypical HSP70s were among the
first genes to be cloned in Leishmania, because of their pre-
sumed importance in its life cycle, and also by technical
reasons; that is, the high evolutionary conservation of HSP70
genes allowed their identification by hybridization using
heterologous genes as probes (reviewed in [15]). In the Leish-
mania species analyzed to date, the HSP70 locus consists of
six-seven gene copies arranged tandemly in a head-to-tail
organization [102, 103]. The first five genes (named HSP70-I)
are identical, whereas gene 6 (HSP70-II), located at the 3󸀠-end
of the locus, differs only in the sequence of the 3󸀠-untranslated
region (UTR). These 3󸀠-UTRs regulate the translational effi-
ciency of the HSP70 mRNAs. Thus, while the HSP70-I tran-
scripts are associated with ribosomes at both normal and
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Figure 3: Relationships inferred from the amino acid sequence
similarities existing among the members of human and L. major
HSP70 families. The phylogeny was inferred using the neighbor-
joining method. The optimal tree with the sum of branch length =
7.43402253 is shown. The evolutionary distances were computed
using the Poisson correction method. All positions containing gaps
andmissing data were eliminated.There were a total of 474 positions
in the final dataset. Evolutionary analyses were conducted in
MEGA6 [8]. See Table 2 for further details of the protein sequences
used for this analysis.
heat-shock temperatures, HSP70-II transcripts are translated
specifically during heat shock [104]. Although promastigotes
lacking the HSP70-II gene could be obtained, they showed
many cellular and biochemical alterations, together with a
reduced virulence [105].
Upon being taken up bymacrophages, parasites are expo-
sed not only to heat shock, but also to various macrophage
defense mechanisms including release of reactive oxygen
species, all of which heighten parasite oxidative stress. Exper-
imentally, it has been demonstrated that a previous heat shock
treatment of Leishmania (mimicking natural heat shock
occurring during transmission to the vertebrate host) leads
to increased parasite resistance to oxidative stress. A direct
involvement of HSP70 in resistance to macrophage induced
oxidative stress was determined with experiments in which
HSP70 was overexpressed in L. chagasi promastigotes [106].
6. Chaperonins
Chaperonins are divided into two groups: group I chaperon-
ins (or HSP60) are mostly found in prokaryotes, mitochon-
dria, and plastids, and group II chaperonins (TRiC/CCT) are
in archaea and the eukaryotic cytosol [107, 108]. The best
characterized chaperonin of group I is the GroEL protein
of E. coli [109]. The GroE machinery consists of 14 GroEL
subunits, arranged in a cylinder of two heptameric rings, to
which the cochaperone GroES, also a heptameric ring, binds.
Inside each ring, a large cavity with a lining of largely hydro-
phobic amino acid residues allows interacting with and acco-
mmodating unfolded polypeptide chains up to a size of about
50 kDa. Remarkably, each one of the two rings, alternately,
experiences cycles of ATP binding and hydrolysis. Upon ATP
binding, the GroEL ring recruits the cochaperonin GroES
ring, whichwill cap the cavity; the assembly of theGroES ring
induces a dramatic structural reorganization in the GroEL
subunits and the enclosed chamber changes from hydropho-
bic lining (in the open ring) to a hydrophilic lining [110].
This decrease in hydrophobicity would favor the folding of
nonnative polypeptides with exposed hydrophobic surfaces
that were trapped inside the open GroEL ring [111]. Once the
substrate is encapsulated in the chamber, the slow hydrolysis
of ATP (half-time ∼ 10 s) provides time for correct folding of
the encapsulated polypeptide. ATP hydrolysis is not required
for protein folding; rather, ATP hydrolysis in the GroES-
bound ring is a prerequisite for ATP binding to the opposite
ring. Currently, the bacterial chaperonin GroE machinery is
the best understood among the chaperone systems devoted to
folding of nascent or stress-denatured polypeptides [11]. The
closely related proteins to GroEL and GroES inmitochondria
are called HSP60 and HSP10, respectively.
The architecture of the CCT (or TRiC) machinery resem-
bles that of GroE machinery; group II chaperonins also form
large cylindrical oligomers consisting of two rings arranged
back to back. Each ring contains a central cavity in which
nonnative proteins are encapsulated in an ATP-dependent
process for folding into the native state [112]. In group II, an
extra protein domain replaces group I cochaperonin GroES/
HSP10 [113].
Another major difference between the two groups of cha-
peronins is that those of group I form homomultimers, while
there is a heterooligomeric assembly in group II. In yeast, for
example, the CCT or TRiC machinery is a large cylindrical
900-kDa oligomer composed of a double-ring structure. Each
heteromeric ring contains eight different 60-kDa subunits
surrounding the cavity where substrates are folded [114].
All eight subunits, Cct1 to Cct8, are essential and expressed
constitutively under normal conditions. The subunits share
30 to 35% of sequence identity, with the highest level of
conservation within the ATPase domain, and the substrate-
binding domains being highly divergent [114].
An L. major HSP60 gene was cloned, and the protein
was shown to be a prominent antigen recognized by sera
from leishmaniasis patients [115]. In L. donovani, two dis-
tinct HSP60 genes were identified [116]. One of the genes,
cpn60.1, though actively transcribed, is not expressed to
detectable levels of protein in axenically cultured parasites.
In contrast, the other gene, cpn60.2, is really expressed as
protein and its abundance increases 2.5-fold under heat
shock and in axenic amastigotes (in comparison with the
levels present in promastigotes). As expected, this HSP60
locates in the mitochondrial matrix [116]. In L. major,
the orthologs are LmjF.32.1850 (cpn60.1) and LmjF.36.2020
(cpn60.2). Two additionalHSP60 coding genes (LmjF30.2820
and LmjF36.2030) were identified after mining the L. major
genome database [15]. The existence of several HSP60 iso-
forms has been observed in some bacteria and also in
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Table 3: Classification of L.major HSP40s according to their structural features.
Name1 GeneDB ID Size2 J domain G/F-rich Zn-finger Type Remarks
J1 LmjF32.3030 329 14–76 — — III
J2 LmjF27.2400 396 6–70 78–94 120–205 I
J3 LmjF21.0490 448 6–71 82–99 125–210 I
J4 LmjF15.1220 478 6–71 87–115 144–227 I
J5 LmjF36.1330 316 39–111 123–135 — II
J6 LmjF36.6270 345 4–70 93–125 — II GMPG repeats
J7 LmjF32.1940 323 3–71 78–105 — II
J8 LmjF24.0520 795 43–111 — — III
J10 LmjF17.0460 216 36–103 139–166 — II
J11 LmjF04.0780 573 9–72 — — III
J13 LmjF18.1490 184 14–93 — — III
J14 LmjF08.0990 326 22–95/164–233 — — III Two J domains
J15 LmjF19.0080 432 5–67 — — III
J16 LmjF20.1130 653 137–202 210–242 — II
SANT, DNA-binding domain
(513–567) SMART accession number:
SM00717
J17 LmjF12.1110 733 88–143 148–209 — II
J18 LmjF27.0410 321 16–80 — — III
J19 LmjF34.4080 257 29–115 131–147 — II
J20 LmjF36.0610 261 172–239 — — III J domain at C-terminus
J21 LmjF26.1410 536 405–474 — — III J domain at C-terminus
J22 LmjF36.2110 286 19–83 111–124 — II
J23 LmjF18.0330 244 49–112 — — III
J24 LmjF30.1790 456 27–89 134–167 — II
J25 LmjF26.1270 852 391–468 479–500 — II J domain in the middle
J26 LmjF17.0040 262 84–146 — — III
J27 LmjF04.0940 487 86–150 156–210 247–325 I
J28 LmjF26.1200 646 282–346 365–389 — II J domain in the middle
J29 LmjF24.1080 436 376–436 — — III J domain at C-terminus
J30 LmjF07.0780 299 — — — — Truncated in L.major
J31 LmjF26.0940 843 36–106 — — IV
J32 LmjF25.2190 377 8–74 80–119 322–351 I
J33 LmjF36.4470 275 7–69 — — III
J34 LmjF35.4630 491 134–203 202–240 — II
J35 LmjF14.0110 523 444–514 — — III J domain at C-terminus
J36 LmjF25.1690 278 60–154 — — III
J37 LmjF18.1430 1119 5–70 — — III
J38 LmjF30.2450 336 15–69 — — III
J40 LmjF10.1050 276 40–108 — — III
J41 LmjF31.0510 596 283–348 360–391 — II J domain in the middle
J42 LmjF18.1650 580 518–580 — — III J domain at C-end; Tetratricopeptiderepeat domain (TPR, 136–463)
J43 LmjF35.4040 388 4–109 — — III
J44 LmjF31.3100 217 18–89 — — II
J45 LmjF32.3300 400 54–121 139–159 176–259 I
J46 LmjF25.1100 395 54–123 142–149 174–257 I
J47 LmjF20.0550 545 350–483 — 257–335 IV J domain at C-terminus
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Table 3: Continued.
Name1 GeneDB ID Size2 J domain G/F-rich Zn-finger Type Remarks
J49 LmjF30.1030 416 52–119 — — III
J50 LmjF35.2980 478 48–109 119–164 185–270 I
J51 LmjF34.2430 808 700–770 775–807 — II J domain at C-end; two TPR domains(345–451 and 572–677)
J52 LmjF36.0500 510 377–448 455–510 — II
J domain at C-end, 2 Tetratricopeptide
repeat (TPR) domains: 17–118 and
254–359
J53 LmjF14.1330 564 431–503 513–560 — II J domain at C-terminus; two TPRdomains (49–118 and 221–288)
J54 LmjF33.0900 580 3–66 85–140 — II
J55 LmjF28.1270 472 9–80 — — III
J56 LmjF33.2690 267 45–136 — — III
J57 LmjF29.1890 395 14–86 144–177 — II
J58 LmjF24.1300 807 15–87 — — III
J59 LmjF30.2210 2458 1384–1463 — — III putative endosomal trafficking proteinRME-8
J60 LmjF09.1440 413 42–110 — — III
J61 LmjF08.0650 286 3–78 — — III
J62 LmjF34.0040 679 95–163 — — III
J63 LmjF32.0590 316 40–107 — — III
J64 LmjF07.0770 402 153–221 — — III J domain in the middle
J65 LmjF34.3870 781 707–777 — — III J domain at C-terminus; TPR domain(481–630)
J66 LmjF22.0080 331 156–279 — 52–139 IV J domain at C-terminus
J67 LmjF36.0760 855 779–852 — — III J domain at C-terminus; two TPRdomains (237–338 and 574–645)
J68 LmjF24.1910 121 51–119 — — IV
J69 LmjF36.4970 345 18–89 — — III
J71 LmjF24.0070 439 49–109 — — III
J72 LmjF35.3090 427 20–74 — — III
J73 LmjF26.2520 489 29–86 — — III
J74 LmjF28.1900 655 143–199 — — III
1Nomenclature according to Folgueira and Requena [15].
2Number of amino acids deduced from the annotated gene sequences in the GeneDB database.
eukaryotes. Thus, for example, Mycobacterium tuberculosis
contains two chaperonins, termed 60.1 and 60.2, that exhibit
around 61% sequence identity. Attempts to inactivate these
genes reveal that only the gene encoding the 60.1 protein can
be inactivated [117]. Remarkably, the chaperonin 60.1 protein
ofM. tuberculosis turned out not to be amolecular chaperone
(it does not fold proteins) but to be a potent virulence factor.
Another example, Drosophila melanogaster has four Hsp60
proteins and each seems to serve a distinct function [118].
Thus, it is likely that some HSP60 variants are playing func-
tions other than protein folding in the mitochondria.
Regarding cochaperonin HSP10, it has been studied to
date only in L. donovani, where it is expressed preferentially
under heat shock conditions. Accordingly, the abundance of
HSP10 increased significantly during in vitro differentiation
to the amastigote stage. Furthermore, it was shown that
the protein localizes in the mitochondrion and coprecipitates
with HSP60 [119]. In L. major, HSP10 is encoded by two
genes (LmjF26.0620 and LmjF26.0640) with almost identical
sequence [15].
7. The HSP40/DnaJ Superfamily
HSP40s, also known as dnaJ-like or J domain proteins, are
crucial partners for HSP70 chaperones, and much of the
functional diversity of the HSP70s is driven by this diverse
class of cofactors [16].Theprototypical and foundingmember
of this superfamily is the E. coliDnaJ protein [120]. In general,
HSP40s regulate the HSP70 cycle through stimulation of
ATPase activity of HSP70. ATP hydrolysis is essential for sta-
bilization of the interaction betweenHSP70 and its substrates
(Figure 2).
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Remarkably, HSP40s, in a cell or in a cellular compart-
ment, outnumber HSP70 variants. Thus, six DnaJ homolog-
ues have been found in E. coli, 41 DnaJ/HSP40 family mem-
bers in humans [121], and 43 DnaJ-related proteins in P. falci-
parum [122, 123]. Furthermore, J proteins show a large degree
of sequence and structural divergence, in agreement with the
idea that they greatly contribute to the multifunctionality of
the HSP70 machinery [16]. The presence of the J domain is
the family mark for these proteins, and it is essential for their
functional interaction with the HSP70 partner. The J domain
is comprised of approximately 70 amino acids and it exhibits
four alpha-helices (I–IV); the existence of a highly conserved
His-Pro-Asp (HPD) tripeptide motif in the loop region
between helices II and III is another structural feature of the
J domain [122]. The HPD tripeptide seems to be essential
for HSP40 functionality, since variations within the HPD
motif are known to abolish the stimulation of HSP70 ATPase
activity byHSP40 [124]. In addition to the J domain, there are
two regions in the prototypical DnaJ: a Gly/Phe-rich region
(GF domain) and a cysteine-rich zinc-binding domain [125].
The zinc-binding domain is characterized by the presence
of four cysteine-repeat sequences (CXXCXGXG), capable of
coordinating the binding of two zinc ions.
The classification of this large and diverse group ofHSP40
andHSP40-like proteins is a challenge, although the existence
of three categories of HSP40s is widely accepted [125–127].
Type I HSP40s contain, similar to the E. coli DnaJ, the three
domains: the J domain, a Gly/Phe-rich region, and a zinc-
finger domain. Type II HSP40s have the J domain and the
Gly/Phe-rich region but lack the cysteine-rich motif. Finally,
type III HSP40s do not have any of the DnaJ-typical motifs
other than the J domain. More recently, Louw and coworkers
have proposed a fourth group (type IV) that is composed of
HSP40s having a J-like domain inwhich the highly conserved
HPD sequence motif is corrupted [100]. Aside from the
above conserved domains or regions, some DnaJ family
members contain additional domains, which may determine
the functional diversity of DnaJ proteins. Also, more recently,
the presence in someDnaJ proteins of a dimerization domain
at its C-terminal region has been found to be essential for
their chaperone activity ([121] and references therein).
A search in the genome of trypanosomatids for proteins
containing the J domain in their sequence showed the exis-
tence of an enormous number of HSP40s in these parasites:
67 in T. cruzi, 66 in L. major, and 65 in T. brucei [15]. For this
review, we have inspected again the L. major annotated gen-
ome and three new members were discovered. Thus, at least,
69 putative HSP40s (J proteins) were found to be encoded in
the L. major genome (Table 3). Also, following the structural
rules indicated above, the proteins have been grouped within
types I–IV. Hence, eight Leishmania HSP40s may be consid-
ered as J proteins type I, since they contain all three domains
of prototypical DnaJ protein. Another 19 HSP40s belong to
the type II category as they have Gly/Phe-rich segments close
to the J domain but lack an apparent Zn-binding domain.The
largest category is that formed by proteins containing only the
J domain, 37 of them are type III and the other 4 are type IV.
Among the putativeHSP40s listed in Table 3, there is one that
lacks the J domain (protein J30); nevertheless, it was included
in the list because its ortholog in T. brucei (Tb927.8.1010)
contains the J domain at the N-terminal moiety. Thus, the L.
major J30 seems to be a truncated version, which lacks the
N-terminal region (220 amino acids) of T. brucei J30 protein.
Although the J domain is located at the N-terminal region
in most Leishmania HSP40s, there are some J proteins in
which the domain is located at the C-terminal region and a
few of them in which the J domain is located in the middle
of the molecule. This atypical location of J domain in some
HSP40s has been also described for J proteins in yeast [126].
Noticeably, one of the Leishmania HSP40s, J14, contains two
J domains. Another remarkable finding is the existence of
TPR domains in several J proteins; thus, J50, J52, J53, and J67
contain two TPR domains each, whereas a sole TPR domain
is present in J42 and J65 (Table 3). As stated above, the TPR
domain has been found to be a docking site, interacting with
the EEVD motif present at the C-termini of some HSP70
family members and in the C-terminus of HSP90.
In spite of this overwhelming number of HSP40s existing
in Leishmania, none of these molecules have been biochem-
ically characterized to date, and consequently nothing is
known about those potential HSP70-HSP40 partnerships.
However, indications about the relevance in the Leishmania
biology are being glimpsed for some of them based on
proteomic studies addressing posttranslational modifications
occurring during the differentiation process. Thus, L. infan-
tum J2 protein has been found to be phosphorylated on Ser-
ine-89, and the phosphorylation of this residue increased by
3.5-fold at 2.5 h of promastigote-to-amastigote differentia-
tion, reaching an increase in phosphorylation of 22-fold in
full differentiated amastigotes [128]. Such a dramatic increase
in phosphorylation suggests a relevant role for this protein in
the differentiation process from promastigote to amastigote
stage.
8. Small Heat Shock Proteins (sHSPs)
They comprise the most poorly conserved family of molecu-
lar chaperones, showing high heterogeneity both in sequence
and size [129]. Their common trait is the conserved 𝛼-
crystallin domain (ACD; PROSITE profile PS01031), which
was firstly described in the eye-lens protein 𝛼-crystallin,
hence, its name.TheACD is formed by seven or eight antipar-
allel 𝛽-strands that form a 𝛽-sandwich; however, the domain
shows low sequence identity among the different sHSPs.
Thus, unlike other families of HSPs, such as the HSP70 and
HSP90 chaperone families, sHSPs show extensive sequence
variation and evolutionary divergence [18].
The 𝛼-crystallin domain is responsible for dimer forma-
tion, which represent the basic structural unit of many sHSPs
[130]. Additionally, their amino- and carboxyterminal exten-
sions are involved in modulating oligomerization, substrate
binding and chaperoning function [131]. sHSPs can form
large dynamic oligomers and coaggregate with aggregation-
prone proteins for subsequent, efficient disaggregation. They
act in an ATP-independent fashion, but the release of sub-
strate proteins from the transient sHSP reservoirs and their
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refolding often require cooperation with ATP-dependent
chaperone systems, mainly the HSP70 machinery [18]. In
essence, the functional role of sHSPs would be avoiding
aggregation ofmisfolded and/or unstable proteins even in the
absence of stress. Nevertheless, it is unclear how sHSPs recog-
nize nonnative substrates and to what extent they may show
substrate specificity.
sHSPs bind a wide range of cellular substrates; they are
implicated inmanydifferent cellular functions and also in cel-
lular defenses against different stresses, such as high tempera-
ture and oxidative stress [132]. On the other hand, sHSPs have
been shown to be associated with membranes, although they
do not contain transmembrane domains or signal sequences.
Via specific membrane lipid interactions, sHSPs have been
shown to modulate major attributes of the membrane lipid
phase such as the fluidity, permeability, or nonbilayer propen-
sity [133]. Furthermore, recent studies have shown that some
sHSPs localize to the mammalian and plant ER, in which
sHSPs would play protective effects, being indeed relevant in
maintaining ER homeostasis [134].
For many organisms, different sHSPs have been descri-
bed, but they are the result of independent evolution pro-
cesses that have taken place in major groups of organisms.
Thus, many orthologs of all 10 human sHSPs have been iden-
tified in other mammals, but only distinct subsets are found
in other vertebrates, and different vertebrates have unique
paralogs [18]. In Leishmania, and related trypanosomatids,
the number of sHSPs seems to be low. In fact, until recently, a
sole sHSP (HSP20, L. major ID: LmjF.29.2450) was identified
in this group of parasites [15]. However, apart from a report
on the immunoprophylactic potential of L. amazonensis
HSP20 [135], studies about its functional relevance have not
been conducted yet.
In a recent work, using human p23 cochaperone sequence
and the BLAST algorithm, two additional ACD-containing
proteins have been identified in L. donovani [136]. They have
been named HSP23 (the ID for the L. major ortholog is
LmjF.34.0210) and p23 (L. major ID: LmjF.35.4470). In a pre-
vious work [15], using a similar BLAST search, both proteins
were identified as putative p23 (HSP90 cochaperones; see
above). The reason is that both classes of proteins, sHSPs and
p23, adopt topologically similar but sequentially unrelated
structures [137]. The functional relevance of the atypical
HSP23 has been studied L. donovani [136]. The protein is a
stress-inducible protein with a threefold higher abundance
in early amastigotes. Furthermore, generation of HSP23-
null mutants allowed concluding that HSP23 is essential for
Leishmania stress tolerance. In fact, a HSP23 null mutant
line of L. donovani was found to be completely unable to
survive at mammalian tissue temperature and, consequently,
these HSP23-null mutants were noninfectious to primary
macrophages in vitro [136]. Furthermore, in this study, it was
shown evidence that HSP23 also protects against trivalent
antimony (Sb3+), the active principle of pentavalent anti-
mony, one of the main drugs used in clinic against leishma-
niasis.
9. Chaperones in the Endoplasmic Reticulum
and the Unfolded Protein Response (UPR)
The endoplasmic reticulum (ER) is the biggest organelle in
most cell types and it is the point responsible for protein
synthesis and maturation destined for the secretory pathway.
In eukaryotic cells, almost all secreted proteins enter the ER
either during (cotranslational) or soon after their synthesis.
After translocation, proteins are folded by the chaperone
machinery in the ER. Additionally, many proteins that enter
the ER will be posttranslational modified by glycosylation.
The lectins calnexin (Cne1 in yeast) and calreticulin are key
components in the quality control of glycoprotein folding
[138, 139]. Many secreted proteins contain disulfide bonds
that maintain their tertiary or quaternary structures; how-
ever, when disulfide bonds are formed incorrectly or fail to
form, protein misfolding occurs. In order to resolve the imp-
roper covalent disulfide links, protein disulfide isomerases
(PDIs) catalyze the formation, reduction, and isomerization
of disulfide bonds.Therefore, PDI may be considered as bona
fidemolecular chaperones.
On the other hand, a retrograde transport of aberrant
polypeptides from the ER into the cytosol for proteasomal
degradation also exists. This pathway is known as “ER-
associated degradation” (ERAD). When unfolded proteins
accumulate in the ER, the UPR pathway is activated.
Very little is known about the ER secretory pathway in
Leishmania regarding its function in protein folding, quality
control, and stress response. This gap in our knowledge is
somewhat lower after the recent publication of a review about
ER stress responses in Leishmania [140]. For the purpose
of this review, we outline the ER chaperones identified in
Leishmania and the roles played in this organelle regarding
protein folding and secretion.
As shown above, the ER members of the families HSP70
(BiP) and HSP90 (GRP94) have been identified in Leishma-
nia. In this regard, a direct interaction between L. donovani
BiP and protein A2 has been documented [141]. The A2 pro-
tein is expressed predominantly in L. donovani amastigotes,
but it is absent in L. major (the A2 ortholog is a pseudogene
in this species). It has been suggested that A2 is a virulence
factor responsible for viscerotropic survival of L. donovani in
themammalian host. On the other hand, accumulation of BiP
in the ERwas observed after treatment of L.major promastig-
otes with the protein glycosylation inhibitor tunicamycin.
Thus, the upregulation of the chaperone BiP, as part of the
UPR response, would increase the protein folding activity and
prevent protein aggregation, alleviating the ER stress induced
by impaired glycosylation [142].
Another ER molecular chaperone studied in Leishmania
is calreticulin (L. major gene: LmjF.31.2600). Overexpression
of a truncated form of calreticulin in L. donovani leads to
decreased secretion of acid phosphatases (one of the major
secreted glycoproteins), and a lower survival rate of the
parasite into the macrophages. The authors of this study sug-
gest that altering the function of an ER chaperone such as
calreticulin in Leishmania affect the trafficking through the
secretory pathway of proteins that are associated with the
virulence of the parasite [143]. Similarly, overexpression of
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the mutated/inactive form of an L. donovani protein disulfide
isomerase (PDI) led to a reduction in the release of secretory
acid phosphatases, suggesting that PDIs also play a critical
role in the Leishmania secretory pathway [144]. The ortholog
in L. major for this PDI is coded by gene LmjF.06.1050.
10. Molecular Chaperones of
the Mitochondrion
The vast majority of mitochondrial proteins are encoded
in the nucleus and synthesized in the cytosol. Therefore,
many proteins must be posttranslationally translocated in
an unfolded state into the mitochondria. The relevance of
the process is evidenced when considering, for example, that
mitochondria in humans retain only 13 protein coding genes,
but the total number of different mitochondrial reaches over
a thousand. Moreover, this protein traffic represent a unique
challenge, given the presence of two distinct membrane
systems, an inner membrane (IM) and an outer membrane
(OM) in this organelle. To deal with this task, mitochon-
dria possess dedicated chaperone systems to assist in these
processes.Thus,mitochondria contain transportmachineries
in both the IM and the OM for the import of nuclear-
encoded proteins. Components of the OM are named Tom
proteins and the components of the IM are named Tim
proteins. The structure of molecular complexes has been
studied mainly in the mitochondria of the yeast S. cerevisiae
and the fungus Neurospora crassa (reviewed in [145]). The
proteins to be translocated into the mitochondria, presum-
ably transported by cytoplasmic chaperones, are partially
unfolded and interact through their exposed hydrophobic
regions with Tom20, Tom22, or Tom70 proteins. Roughly,
mitochondrial preproteins are thus targeted to mitochondria
either via amino-terminal presequences to Tom20/Tom22
or via internal targeting sequences to Tom70. Subsequently,
proteins are transferred to the general import pore (GIP), a
multiprotein complex formed by at least five different pro-
teins. The preproteins pass through the GIP and are inserted
into the IM import channel, which is formed by a complex of
proteins containing Tim23 and themitochondrial member of
the HSP70 family. Hence, a fraction of themtHSP70 is bound
to the TIM23 complex and serves as the ATP-dependent
motor protein for mitochondrial protein import. The differ-
ence of potential between the mitochondrial intermembrane
and matrix also contributes to protein import of prepro-
teins. During import, cycles of ATP-hydrolysis by mtHSP70
generates the pulling force to introduce the preprotein into
the mitochondrial matrix; in the process, the nucleotide
exchange factor, Mge1, and two J domain proteins (Pam16
and Pam18) are also involved. Since preproteins cross the
membrane in a completely unfolded conformation, due to the
small pore diameter of the translocase complexes, mtHSP70
is also the first chaperone that initiates the folding process of
the imported polypeptide [146]. In agreement with its evolu-
tionary origin, mtHSP70 is more closely related to the bacte-
rial DnaK than to its eukaryotic cytosolic counterparts [147].
Apart from the role of mtHSP70 in the cytoplasmic-
mitochondrial transport, it also participates in the folding
of those proteins that are synthesized by the mitochondrial
translation apparatus and it protects the mitochondrial pro-
teins from misfolding caused by chemical modifications, as
those produced by reactive oxygen species (ROS), and other
stresses. During folding reactions in the matrix, mtHSP70
cooperates closely with the other main chaperone type in
the matrix compartment, HSP60 (see section chaperonins).
A distinction between the functions in protein translocation
and in protein folding is mainly achieved by the particular
J-family cochaperone that interacts with mtHSP70 during
these processes. The protein Mdj1 (the “mitochondrial DnaJ”
homolog) is involved inmtHSP70-mediated folding reactions
in the matrix compartment [146].
The existence of two distinct mtHSP70s in Leishmania is
noticeable as usually a sole protein is present in the mito-
chondria ofmost organisms, even in related trypanosomatids
[148]. At the amino acid level, the two proteins share an over-
all identity of 91% with the N-terminal end being completely
conserved. Interestingly, expression analysis showed that the
two Leishmania mtHSP70s are differentially expressed, one
is predominant in promastigotes and the other is restricted
to the amastigote stage [148]. In a recent work, the mtHSP70
machinery (mtHSP70,mtHSP40, andMge1) has been studied
in the Leishmania-related trypanosomatid T. brucei [149].
Based on the information provided in this study, it was
possible to identity the L. major homologues for mtHSP40
and Mge1 as the genes LmjF35.2980 (J50; Table 3) and
LmjF30.0730, respectively. Remarkably, in the work by Ty´cˇ et
al. [149], using RNA interference- (RNAi-) mediated deple-
tion of each of these three proteins, evidence was obtained
that the entire mtHSP70 machinery plays a relevant role in
mitochondrial DNA replication and maintenance.
In an outstanding work, Teixeira and coworkers [150]
have elegantly shown that mitochondrial peroxiredoxin
mTXNPx in L. infantum functions as a crucial chaperone,
allowing L. infantum to deal successfully with protein unfold-
ing conditions during the transition from insect to the
mammalian hosts. Peroxiredoxins (Prxs, EC 1.11.1.15) are ubi-
quitous antioxidant enzymes, found in all kingdoms of life,
that help to control intracellular peroxide levels [151]. Recent
studies suggested that Prxs may eject also molecular chap-
erone functions; however, little is known about the precise
mechanismof chaperone function and its physiological signi-
ficance.The studies with L. infantummTXNPX have demon-
strated that, in this parasite, the reduced form of the protein
is a stress-specific chaperone reservoir, which is activated
rapidly upon exposure to unfolding stress conditions [150].
In a previous article, the group showed that mTXNPx-
deficient promastigotes are significantly more sensitive to a
temperature shift from 25∘C to 37∘C thanwild-type promasti-
gotes and, consequently, the mTXNPx-deficient parasites
were unable to survive within the mammalian host [152].
Interestingly, these phenotypes could not be attributed to
the peroxidase function of mTXNPx, because an L. infantum
line expressing a peroxidase-inactive variant of mTXNPxwas
fully capable of surviving the temperature shift to 37∘C and
infecting mice. These results suggest that the essential func-
tion observed in vivo is not based on the peroxidase activity
but more likely involves a second function of mTXNPx,
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presumably a chaperone role. This atypical chaperone func-
tion has been demonstrated recently [150]. The reduced
mTXNPx, structured as a decameric complex interacts with
unfolded proteins, protecting them against temperature-
induced aggregation.Therefore, mTXNPx is a relevant player
of themitochondrial proteostasis network, and its role as cha-
perone is crucial for parasite infectivity.
11. Selective Targeting of
Chaperones as a Therapeutic Strategy
against Leishmaniasis
HSP90,HSP70 and their cochaperones have been shown to be
critical for the growth of a variety of different human tumor
cell lines in which these chaperones are expressed at elevated
levels. Therefore, these HSPs are currently considered as
potentially targets in cancer and the inhibitory activity of
many compounds are being experimentally addressed [153].
To date, there are few studies addressing the effect of mol-
ecular chaperone inhibitors as leishmanicidal drugs. In recent
studies, the in vitro effect of 17-(allylamino)-17-demethox-
ygeldanamycin (17-AAG) against L. amazonensis, L. infan-
tum, L. major, and L. panamensis promastigotes was demon-
strated [154, 155]. Moreover, the in vitro treatment of Leish-
mania-infectedmacrophageswith nanomolar concentrations
of 17-AAG promoted the clearance of parasite infection [154].
The compound 17-AAG is a potent inhibitor for HSP90, and
it is currently in clinical trials for cancer treatment [156].
Additionally, in preclinical studies with mouse models, 17-
AAG has been found to inhibit the growth of P. falciparum
and Trypanosoma evansi [157]. In a recent report, it has been
demonstrated that 17-AAG is also efficient in reducing L.
braziliensis promastigote growth, macrophage infection, and,
more importantly, the parasitemultiplication in vivo (BALB/c
mice), highlighting its potential as a novel chemotherapy
agent against cutaneous leishmaniasis caused by L. brazilien-
sis [158].
12. Chaperones and Drug Resistance in
Leishmania: The Other Side of the Coin
Control of leishmaniasis relies mostly on chemotherapy [3],
given the lack of an effective vaccine and the difficulties to
control the vector (sandfly). Nevertheless, treatment failure is
increasing due to the emergence of parasites resistant to the
most common antileishmanial drugs in several parts of the
world, and most notably in India [159].
Pentavalent antimony, Sb(V), is the first line drug for
patients with leishmaniasis in most parts of the world but
acquired resistance against antimonials is high and common
in some parts, such as the Indian subcontinent. Given the
relevance of stress proteins in protecting cells from toxic
external stimuli, it is not surprising the association observed
between drug resistance and increased levels of these proteins
in many types of cells, and this is true also for Leishmania.
Thus, antimony resistant L. tarentolae promastigotes accu-
mulate 4-fold more HSP70 than the wild-type cells [160].
Moreover, when the HSP70 was overexpressed in this Leish-
mania species, a significantly increased resistance to pentava-
lent antimony was observed. Similarly, increased amounts
of HSP70 have been found in antimony-resistant clinical
isolates of L. donovani. Noticeably, the resistant isolates con-
tain increased levels (about 5-fold more protein) for both
the cytoplasmic prototypical HSP70 and the mitochondrial
HSP70 [161]. In another study with L. donovani clinical
isolates, among the 12 overexpressed proteins in antimony
resistant parasites, the cytosolic HSP70 and a membrane-
associated fragment of HSP83/90 were identified [162]. Also,
accumulation of HSP90 was previously observed in a study
in which the proteomics of Sb(V)-sensitive and -resistant
L. donovani strains, isolated from kala-azar patients, were
compared [163]. Interestingly, overexpressing of HSP90 in a
Sb-sensitive strain led to increased resistance to antimony
and, noticeably, transfectants were also cross-resistant to
miltefosine, another drug used for treatment of visceral leish-
maniasis. In that work and in a previous article from the
group [160], it has been suggested that HSP70 and HSP83
may interact with other proteins to negatively regulate the
mitochondria-dependent apoptotic pathway that some drugs
are activating in the parasite.
It has been suggested that antimonials kill cells by a pro-
cess resembling programmed cell death (PCD) or apoptosis
[164]. Current evidence also suggests that miltefosine treat-
ment of L. donovani promastigotes leads to induce cellular
alterationswith features ofmetazoan apoptosis, including cell
shrinkage, DNA fragmentation into oligonucleosome-sized
fragments, and changes in membrane composition [165].
The increased expression of HSP90 in antimony resistant
parasites has led to some authors to propose a role for HSP90
in protecting Leishmania from drug-induced PCD [163].This
hypothesis is based also on the fact that HSP90 and also
HSP70 have been found to be a negative regulator of themito-
chondrial cytochrome c-dependent apoptosis pathway in
many cells and organisms [166]. Further support about the
antiapoptotic properties of HSP90 has been obtained from
studies in L. donovani parasites overexpressing histone H1.
The level of HSP90 was found to decrease in promastigotes
transfected with the histone H1 coding gene, and, interest-
ingly, parasites overexpressing H1 were more susceptible to
heat-shock and drug-induced apoptosis [167].
In certain regions of India, resistance to Sb(V) is so
widespread that alternative drugsmust be used as first choice.
Amphotericin B (AmB) in its liposomal form is currently
considered as the more effective drug available against vis-
ceral leishmaniasis, even though its high cost prevents their
utilization in most affected countries [168]. Since some cases
of drug resistance have been reported, studies intended to
determine the AmB resistancemechanisms have been under-
taken. Recently, a large-scale comparative proteomic study
was carried out to identify proteins differentially expressed
in an in vitro selected AmB resistant L. infantum line [169].
Many proteins involved in protein folding, such as heat-
shock proteins and chaperonins, were found among the up-
regulated proteins in this line, suggesting a putative role of
these proteins in AmB resistance or tolerance. In particular,
the heat shock proteins HSP90, HSP60, and cytoplasmic and
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mitochondrial members of HSP70 were found to be clearly
upregulated in AmB resistant parasites.
In L. major lines resistant to the antifolate methotrexate,
mitochondrial HSP70 (LmjF30.2470) and a type-3 HSP60
(LmjF36.2030) were found among the proteinsmore strongly
overexpressed [170].
Increased expression of HSP70 mRNAs has been found
in L. donovani amastigotes showing resistance to nelfi-
navir [171], an HIV-1 protease inhibitor, which was recently
described as a powerful inhibitor of the intracellular growth
of Leishmania in primary human monocyte-derived macro-
phages [172].
13. Concluding Remark and Future Tasks
We now have in hand most of the molecular chaperones
existing in the different cellular compartments in Leishmania.
The challenge for the future will be to understand how these
distinct molecules work and how they are organized into
functional networks to promote the life of this pathogen.
Also, understanding of the mechanisms by which molecular
chaperones detect stress and transduce signals is an impor-
tant research field that requires further efforts. A rapid expan-
sion in our knowledge about Leishmania biology will allow
developing therapeutic strategies to combat leishmaniases.
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